Nikhil Chopra to now spearhead JB Chemicals, appointed as Director, CEO

Published On 2020-10-06 07:19 GMT   |   Update On 2022-12-07 06:44 GMT

New Delhi: Former Cipla India Business Head, Nikhil Chopra, will now lead J B Chemicals & Pharmaceuticals as its's board has appointed him as Whole-time Director and Chief Executive Officer of the company.

"The board of directors of the company has appointed Chopra as Whole-time Director and CEO for a period of five years," J B Chemicals & Pharmaceuticals said in a filing to the BSE.

Prior to joining the company, Chopra worked as Head-India Business at Cipla Ltd, it added.

With a 24 years stint at Cipla since 1996, Chopra had been instrumental in integrating the generics business, worth around Rs 6000 crore. He had played a key role in Cipla's initiative of "Go Beyond the Pill" through patient awareness and facilitating low-cost diagnostic options in respiratory treatment.

He had played important role in integrating around 20 businesses of the company into 4 major clusters.

Advertisement

Also Read: Mega Exit: Cipla India Top Boss, 2 Senior Executives Step Out After 24 Year Stint

Chopra has over 20 years of experience backed up with a consistent record of sustainable growth and shareholder value creation, the filing said.

He holds M.Sc. in Organic Chemistry from Gujarat University, reports PTI.

Tags:    
Article Source : with agency inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News